CEFAZOLIN SODIUM

CEFAZOLIN SODIUM was reported 12206 times

CEFAZOLIN SODIUM is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 LYMPHOID TISSUE HYPOPLASIA 87 0.5686
1 THYMUS HYPOPLASIA 85 0.4885
2 MULTIPLE LENTIGINES SYNDROME 13 0.3421
3 HYPOPROTHROMBINAEMIA 64 0.2126
4 PERICARDITIS FUNGAL 12 0.1818
5 MECHANICAL VENTILATION COMPLICATION 27 0.1812
6 DISSEMINATED ASPERGILLOSIS 82 0.1737
7 MYCOBACTERIAL PERITONITIS 16 0.1684
8 GASTRITIS FUNGAL 12 0.1165
9 ALLERGY TEST NEGATIVE 17 0.1090
10 PURPURA SENILE 13 0.1066
11 POST PROCEDURAL HYPOTENSION 9 0.1059
12 MYCOBACTERIUM FORTUITUM INFECTION 19 0.1027
13 VITAMIN K DEFICIENCY 41 0.1020
14 INSPIRATORY CAPACITY DECREASED 27 0.0975
15 BURKHOLDERIA TEST POSITIVE 11 0.0887
16 RECURRENCE OF NEUROMUSCULAR BLOCKADE 14 0.0819
17 AIRWAY PEAK PRESSURE INCREASED 12 0.0789
18 MYOCARDIAL CALCIFICATION 9 0.0769
19 CONFUSION POSTOPERATIVE 10 0.0763
20 POSTOPERATIVE DELIRIUM 15 0.0758
21 ARTHRODESIS 70 0.0688
22 CHORIOAMNIONITIS 13 0.0684
23 VANCOMYCIN INFUSION REACTION 23 0.0610
24 TARSAL TUNNEL SYNDROME 13 0.0591
25 INCISION SITE INFECTION 44 0.0485
26 MENINGITIS FUNGAL 10 0.0426
27 CLOSTRIDIUM TEST POSITIVE 89 0.0403
28 MATERNAL EXPOSURE DURING DELIVERY 35 0.0353
29 PROCEDURAL HYPOTENSION 30 0.0353
30 KOUNIS SYNDROME 80 0.0352
31 FOETAL EXPOSURE DURING DELIVERY 23 0.0339
32 TRYPTASE INCREASED 22 0.0308
33 AIRWAY COMPLICATION OF ANAESTHESIA 8 0.0304
34 PYROGLUTAMIC ACIDOSIS 11 0.0277
35 CATARACT SUBCAPSULAR 16 0.0262
36 ALLERGIC OEDEMA 17 0.0262
37 HYPERTHERMIA MALIGNANT 39 0.0262
38 CIRCUMORAL OEDEMA 9 0.0258
39 SPINAL CORD OEDEMA 9 0.0243
40 ANAPHYLACTIC SHOCK 622 0.0241
41 DIABETIC RETINAL OEDEMA 12 0.0236
42 LINEAR IGA DISEASE 37 0.0222
43 URTICARIAL VASCULITIS 11 0.0208
44 DYSBIOSIS 17 0.0207
45 CYTOMEGALOVIRUS VIRAEMIA 92 0.0207
46 EPISCLERITIS 14 0.0203
47 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 157 0.0202
48 DELAYED RECOVERY FROM ANAESTHESIA 19 0.0200
49 ANTIBIOTIC LEVEL ABOVE THERAPEUTIC 8 0.0197
50 TOXIC SHOCK SYNDROME 11 0.0175
51 RED MAN SYNDROME 15 0.0170
52 DELIVERY 11 0.0167
53 PSEUDOMONAL SEPSIS 29 0.0165
54 CARDIAC VALVE VEGETATION 8 0.0165
55 CLOSTRIDIUM DIFFICILE COLITIS 173 0.0163
56 SCEDOSPORIUM INFECTION 11 0.0156
57 POST PROCEDURAL HAEMATOMA 26 0.0154
58 MYCOPLASMA INFECTION 12 0.0154
59 AMNIOTIC CAVITY INFECTION 11 0.0152
60 HAEMOTHORAX 44 0.0152
61 EOSINOPHILIC MYOCARDITIS 11 0.0151
62 RESORPTION BONE INCREASED 12 0.0146
63 BRONCHOSTENOSIS 8 0.0146
64 ACINETOBACTER INFECTION 16 0.0146
65 BRAIN HERNIATION 43 0.0144
66 DELAYED GRAFT FUNCTION 10 0.0141
67 FUNGAEMIA 22 0.0140
68 SHOULDER ARTHROPLASTY 37 0.0137
69 RASH MORBILLIFORM 38 0.0137
70 STAPHYLOCOCCAL BACTERAEMIA 59 0.0136
71 SYMMETRICAL DRUG-RELATED INTERTRIGINOUS AND FLEXURAL EXANTHEMA 11 0.0134
72 ADRENAL SUPPRESSION 11 0.0130
73 VASCULAR PURPURA 18 0.0129
74 DIABETES INSIPIDUS 31 0.0129
75 SKIN TEST POSITIVE 12 0.0129
76 HYPOVITAMINOSIS 17 0.0128
77 MALIGNANT HYPERTENSION 11 0.0128
78 TINEA INFECTION 14 0.0127
79 LYMPHOCYTE STIMULATION TEST POSITIVE 10 0.0125
80 STRONGYLOIDIASIS 20 0.0124
81 SEPSIS NEONATAL 10 0.0123
82 ANAESTHETIC COMPLICATION 33 0.0123
83 MYCOBACTERIUM CHELONAE INFECTION 9 0.0122
84 ANAPHYLACTIC REACTION 659 0.0119
85 PSEUDOMONAL BACTERAEMIA 10 0.0117
86 TYPE I HYPERSENSITIVITY 41 0.0116
87 NEPHROGENIC ANAEMIA 53 0.0114
88 CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER 12 0.0113
89 INFANTILE APNOEA 9 0.0110
90 BLOOD CREATINE PHOSPHOKINASE MB INCREASED 14 0.0109
91 BRADYCARDIA FOETAL 9 0.0108
92 HYPERPARATHYROIDISM SECONDARY 27 0.0108
93 VESTIBULAR DISORDER 13 0.0106
94 PSEUDOMEMBRANOUS COLITIS 23 0.0103
95 CROSS SENSITIVITY REACTION 10 0.0103
96 EMPYEMA 20 0.0101
97 BRONCHOSPASM 143 0.0100
98 KLEBSIELLA SEPSIS 11 0.0098
99 SKIN GRAFT 9 0.0097
100 GLOMERULAR FILTRATION RATE ABNORMAL 13 0.0092
101 CUTANEOUS VASCULITIS 33 0.0090
102 CHOLESTATIC LIVER INJURY 20 0.0090
103 DEVICE RELATED SEPSIS 18 0.0089
104 SHOCK HAEMORRHAGIC 72 0.0088
105 INTRAVENTRICULAR HAEMORRHAGE 22 0.0088
106 TINEA PEDIS 14 0.0088
107 CHRONIC SPONTANEOUS URTICARIA 10 0.0086
108 PULSELESS ELECTRICAL ACTIVITY 35 0.0084
109 GAZE PALSY 14 0.0082
110 MULTI-ORGAN FAILURE 142 0.0082
111 HEPARIN-INDUCED THROMBOCYTOPENIA 40 0.0081
112 CATHETER SITE HAEMORRHAGE 20 0.0080
113 MIXED LIVER INJURY 24 0.0080
114 LYMPHOPENIA 112 0.0079
115 STRIDOR 23 0.0078
116 INTENSIVE CARE 11 0.0077
117 EMBOLIC STROKE 27 0.0077
118 OSTEOSCLEROSIS 12 0.0076
119 HYPOVOLAEMIA 44 0.0075
120 CLOSTRIDIUM COLITIS 9 0.0074
121 CARDIOVASCULAR INSUFFICIENCY 12 0.0074
122 ARTHRITIS BACTERIAL 30 0.0073
123 LIMB OPERATION 35 0.0073
124 VASCULAR DEVICE INFECTION 33 0.0073
125 RETROPERITONEAL HAEMATOMA 16 0.0072
126 INFECTIOUS PLEURAL EFFUSION 11 0.0072
127 ENDOCARDITIS 37 0.0072
128 FEAR OF DEATH 16 0.0071
129 NECROTISING COLITIS 9 0.0071
130 HAEMODYNAMIC INSTABILITY 54 0.0071
131 ANAPHYLACTOID REACTION 29 0.0070
132 OTOTOXICITY 13 0.0070
133 PELVIC VENOUS THROMBOSIS 10 0.0070
134 TYPE IV HYPERSENSITIVITY REACTION 19 0.0069
135 CYSTOID MACULAR OEDEMA 13 0.0069
136 ACUTE FEBRILE NEUTROPHILIC DERMATOSIS 16 0.0069
137 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 177 0.0069
138 VERTIGO POSITIONAL 12 0.0068
139 TOXIC EPIDERMAL NECROLYSIS 104 0.0068
140 NODAL RHYTHM 10 0.0068
141 COAGULOPATHY 113 0.0068
142 DEVICE RELATED INFECTION 103 0.0067
143 RENAL INJURY 198 0.0067
144 ELECTROCARDIOGRAM ST SEGMENT ELEVATION 22 0.0066
145 FEAR 178 0.0066
146 LUNG OPACITY 17 0.0064
147 ATELECTASIS 62 0.0064
148 ELECTROCARDIOGRAM ST SEGMENT DEPRESSION 14 0.0064
149 TONGUE OEDEMA 24 0.0063
150 LABELLED DRUG-DRUG INTERACTION ISSUE 9 0.0062
151 STAPHYLOCOCCUS TEST POSITIVE 13 0.0062
152 ANHEDONIA 162 0.0062
153 RESPIRATORY ALKALOSIS 10 0.0061
154 NORMOCYTIC ANAEMIA 9 0.0061
155 HYPERSENSITIVITY VASCULITIS 16 0.0061
156 PNEUMONIA STAPHYLOCOCCAL 12 0.0061
157 DISSEMINATED INTRAVASCULAR COAGULATION 85 0.0060
158 PNEUMONIA KLEBSIELLA 11 0.0060
159 THROMBOPHLEBITIS SUPERFICIAL 18 0.0059
160 EXCORIATION 15 0.0059
161 EOSINOPHILIA 103 0.0059
162 RASH MACULO-PAPULAR 129 0.0058
163 BACTERIAL INFECTION 108 0.0058
164 COMPLICATIONS OF TRANSPLANTED KIDNEY 13 0.0057
165 MEGACOLON 9 0.0057
166 FOETAL DISTRESS SYNDROME 12 0.0057
167 NEONATAL RESPIRATORY DISTRESS SYNDROME 20 0.0056
168 END STAGE RENAL DISEASE 103 0.0056
169 HEPATITIS CHOLESTATIC 34 0.0056
170 WOUND DEHISCENCE 19 0.0056
171 DIABETIC RETINOPATHY 19 0.0056
172 IMPLANT SITE INFECTION 13 0.0056
173 PNEUMONIA FUNGAL 22 0.0056
174 KLEBSIELLA INFECTION 28 0.0055
175 HYPOVENTILATION 18 0.0055
176 STRESS CARDIOMYOPATHY 32 0.0055
177 STAPHYLOCOCCAL SEPSIS 27 0.0055
178 SOFT TISSUE INFECTION 10 0.0055
179 TOXIC SKIN ERUPTION 55 0.0055
180 CALCIPHYLAXIS 10 0.0054
181 LOW BIRTH WEIGHT BABY 43 0.0054
182 TORSADE DE POINTES 42 0.0053
183 ANGIOPATHY 30 0.0053
184 RESPIRATORY ACIDOSIS 21 0.0053
185 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 27 0.0053
186 VENTRICULAR FIBRILLATION 59 0.0053
187 CHOREA 9 0.0052
188 BACTERAEMIA 62 0.0052
189 PARAPLEGIA 15 0.0052
190 PROTHROMBIN TIME PROLONGED 31 0.0052
191 VASCULAR PSEUDOANEURYSM 9 0.0052
192 RENAL TUBULAR NECROSIS 50 0.0051
193 BLOOD PRESSURE SYSTOLIC DECREASED 23 0.0051
194 BLOOD CHLORIDE DECREASED 13 0.0050
195 PERICARDIAL HAEMORRHAGE 11 0.0050
196 BUNDLE BRANCH BLOCK RIGHT 23 0.0050
197 ENDOTRACHEAL INTUBATION 14 0.0050
198 LIP OEDEMA 21 0.0050
199 LIVER ABSCESS 16 0.0049
200 GENERALISED ERYTHEMA 28 0.0049
201 TUBULOINTERSTITIAL NEPHRITIS 92 0.0049
202 RETROPERITONEAL HAEMORRHAGE 12 0.0049
203 FACE OEDEMA 82 0.0049
204 PREMATURE DELIVERY 77 0.0048
205 APLASTIC ANAEMIA 25 0.0048
206 CARDIOGENIC SHOCK 68 0.0047
207 HYPERCAPNIA 14 0.0046
208 HEPATIC CYTOLYSIS 59 0.0046
209 MUCORMYCOSIS 12 0.0046
210 PERIODONTITIS 10 0.0046
211 WOUND SECRETION 18 0.0046
212 KIDNEY TRANSPLANT REJECTION 22 0.0046
213 PNEUMOTHORAX 72 0.0045
214 NECROTISING FASCIITIS 16 0.0045
215 ANURIA 39 0.0045
216 AZOTAEMIA 18 0.0045
217 CIRCULATORY COLLAPSE 76 0.0045
218 MACULAR OEDEMA 25 0.0045
219 PULMONARY ALVEOLAR HAEMORRHAGE 25 0.0045
220 LEUKOCYTOSIS 80 0.0044
221 PATHOGEN RESISTANCE 40 0.0044
222 TRANSPLANT REJECTION 35 0.0044
223 VENTRICULAR TACHYCARDIA 72 0.0044
224 DRUG-INDUCED LIVER INJURY 136 0.0043
225 APPENDICITIS PERFORATED 11 0.0043
226 CELLULITIS 218 0.0043
227 HYPOXIA 152 0.0043
228 SEDATION COMPLICATION 11 0.0043
229 POST PROCEDURAL COMPLICATION 82 0.0043
230 EMPHYSEMA 43 0.0043
231 PREMATURE BABY 128 0.0042
232 HYDROCEPHALUS 23 0.0042
233 OLIGURIA 26 0.0042
234 LONG QT SYNDROME 10 0.0042
235 POSTOPERATIVE WOUND INFECTION 28 0.0041
236 CLOSTRIDIAL INFECTION 14 0.0041
237 ELECTROENCEPHALOGRAM ABNORMAL 13 0.0041
238 PERITONITIS BACTERIAL 41 0.0041
239 BLOOD CREATININE ABNORMAL 14 0.0040
240 VENTRICULAR HYPOKINESIA 13 0.0040
241 STUPOR 13 0.0040
242 HAEMOLYTIC ANAEMIA 36 0.0040
243 HEPATIC ENZYME ABNORMAL 20 0.0040
244 BLOOD CULTURE POSITIVE 12 0.0040
245 DRUG ERUPTION 71 0.0040
246 THYROIDITIS 12 0.0040
247 ENCEPHALOPATHY 98 0.0040
248 ARTERIOSPASM CORONARY 16 0.0040
249 ORGAN FAILURE 16 0.0040
250 HYPOTHERMIA 40 0.0039
251 ENTEROCOCCAL INFECTION 19 0.0039
252 SHOCK 90 0.0039
253 PROCEDURAL COMPLICATION 30 0.0039
254 LARYNGEAL OEDEMA 24 0.0039
255 PROCEDURAL HAEMORRHAGE 15 0.0038
256 METABOLIC ACIDOSIS 121 0.0038
257 TACHYPNOEA 51 0.0037
258 GENERALISED TONIC-CLONIC SEIZURE 62 0.0037
259 HYPOPNOEA 13 0.0037
260 SINUS TACHYCARDIA 53 0.0037
261 SUBARACHNOID HAEMORRHAGE 38 0.0037
262 HAEMODIALYSIS 31 0.0037
263 DUODENAL ULCER 26 0.0037
264 RENAL FAILURE 488 0.0037
265 THROMBOSIS IN DEVICE 12 0.0037
266 SUBDURAL HAEMORRHAGE 10 0.0037
267 CARDIAC ARREST 301 0.0036
268 PEPTIC ULCER 12 0.0036
269 POST PROCEDURAL HAEMORRHAGE 42 0.0036
270 MYOCLONUS 43 0.0036
271 OLIGOHYDRAMNIOS 12 0.0036
272 THROMBOTIC MICROANGIOPATHY 35 0.0036
273 SERUM SICKNESS 10 0.0036
274 SYSTEMIC CANDIDA 9 0.0036
275 CARDIAC TAMPONADE 17 0.0036
276 ACUTE PULMONARY OEDEMA 20 0.0036
277 HYPOTENSION 711 0.0035
278 BLOOD LOSS ANAEMIA 8 0.0035
279 PHLEBITIS 18 0.0035
280 PURULENT DISCHARGE 15 0.0035
281 RESPIRATORY RATE DECREASED 11 0.0035
282 STAPHYLOCOCCAL INFECTION 115 0.0035
283 INJURY 245 0.0035
284 VENTRICULAR DYSFUNCTION 9 0.0035
285 ENTEROCOLITIS 20 0.0035
286 LUMBAR SPINAL STENOSIS 10 0.0034
287 HYPERURICAEMIA 14 0.0034
288 DERMATITIS EXFOLIATIVE 17 0.0034
289 HEPATITIS ACUTE 22 0.0034
290 HEPATITIS FULMINANT 10 0.0034
291 RESPIRATORY DISTRESS 93 0.0034
292 CONJUNCTIVAL HYPERAEMIA 12 0.0034
293 ACUTE HEPATIC FAILURE 46 0.0034
294 PULSE ABSENT 16 0.0034
295 EOSINOPHIL COUNT INCREASED 28 0.0034
296 LARYNGOSPASM 9 0.0033
297 METABOLIC ENCEPHALOPATHY 10 0.0033
298 HEPATIC ENCEPHALOPATHY 31 0.0033
299 FUNGAL INFECTION 110 0.0033
300 IRITIS 10 0.0033
301 SEPTIC SHOCK 143 0.0033
302 PURPURA 29 0.0033
303 STATUS EPILEPTICUS 37 0.0033
304 MASTICATION DISORDER 10 0.0033
305 ARTHRITIS INFECTIVE 15 0.0032
306 LUNG CONSOLIDATION 9 0.0032
307 APNOEA 25 0.0032
308 INTERNATIONAL NORMALISED RATIO INCREASED 91 0.0032
309 CHOLESTASIS 61 0.0032
310 SEROTONIN SYNDROME 61 0.0032
311 CATHETER SITE INFECTION 12 0.0032
312 TACHYCARDIA 281 0.0032
313 CHRONIC KIDNEY DISEASE 240 0.0032
314 BILE DUCT STONE 10 0.0031
315 HYPERTHERMIA 24 0.0031
316 ACIDOSIS 24 0.0031
317 ILEUS PARALYTIC 14 0.0031
318 BRADYCARDIA 166 0.0031
319 AGRANULOCYTOSIS 58 0.0031
320 JAUNDICE CHOLESTATIC 11 0.0031
321 ACUTE RESPIRATORY DISTRESS SYNDROME 55 0.0031
322 AORTIC ARTERIOSCLEROSIS 8 0.0031
323 UNEVALUABLE EVENT 235 0.0031
324 SKIN EROSION 10 0.0031
325 BLOOD LACTATE DEHYDROGENASE INCREASED 49 0.0031
326 BRAIN OEDEMA 39 0.0031
327 PULMONARY HAEMORRHAGE 24 0.0031
328 DEAFNESS NEUROSENSORY 10 0.0030
329 HYPERVOLAEMIA 15 0.0030
330 PATENT DUCTUS ARTERIOSUS 12 0.0030
331 STEVENS-JOHNSON SYNDROME 67 0.0030
332 WOUND INFECTION 33 0.0030
333 THROMBOCYTOSIS 11 0.0030
334 RENAL IMPAIRMENT 252 0.0030
335 GENERALISED OEDEMA 37 0.0030
336 TOXIC ENCEPHALOPATHY 15 0.0030
337 HEPATIC FUNCTION ABNORMAL 110 0.0029
338 PERIPHERAL ISCHAEMIA 12 0.0029
339 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 28 0.0029
340 CHRONIC SINUSITIS 11 0.0029
341 MULTIPLE ORGAN DYSFUNCTION SYNDROME 83 0.0029
342 CARDIOMEGALY 36 0.0029
343 RENAL FAILURE ACUTE 124 0.0029
344 PSEUDOMONAS INFECTION 25 0.0029
345 MULTIPLE-DRUG RESISTANCE 9 0.0029
346 HAND DEFORMITY 38 0.0029
347 PERIORBITAL OEDEMA 15 0.0029
348 ACUTE KIDNEY INJURY 442 0.0029
349 OSTEOMYELITIS 52 0.0029
350 ANGIOEDEMA 127 0.0029
351 RESPIRATORY DEPRESSION 35 0.0029
352 RIGHT VENTRICULAR FAILURE 20 0.0029
353 DRUG RASH WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 9 0.0028
354 ECCHYMOSIS 19 0.0028
355 ATRIOVENTRICULAR BLOCK FIRST DEGREE 12 0.0028
356 EYELID OEDEMA 32 0.0028
357 CLOSTRIDIUM DIFFICILE INFECTION 60 0.0027
358 URINE OUTPUT DECREASED 24 0.0027
359 VENTRICULAR ARRHYTHMIA 10 0.0027
360 SPINAL OSTEOARTHRITIS 24 0.0027
361 RENAL FAILURE CHRONIC 21 0.0027
362 PNEUMONIA BACTERIAL 25 0.0027
363 ADVERSE REACTION 36 0.0027
364 SUBCUTANEOUS ABSCESS 13 0.0027
365 BLOOD PRESSURE DECREASED 180 0.0027
366 ERYTHEMA MULTIFORME 25 0.0027
367 GANGRENE 16 0.0027
368 CENTRAL VENOUS CATHETERISATION 8 0.0026
369 VENOOCCLUSIVE LIVER DISEASE 13 0.0026
370 DERMATITIS BULLOUS 19 0.0026
371 WOUND COMPLICATION 9 0.0026
372 GAMMA-GLUTAMYLTRANSFERASE INCREASED 58 0.0026
373 RESPIRATORY FAILURE 190 0.0026
374 LUNG INFILTRATION 23 0.0026
375 PANCYTOPENIA 145 0.0026
376 RALES 15 0.0026
377 ABSCESS LIMB 11 0.0026
378 OXYGEN SATURATION DECREASED 145 0.0026
379 PLEURAL EFFUSION 157 0.0026
380 THROMBOPHLEBITIS 9 0.0026
381 ARTERIOSCLEROSIS CORONARY ARTERY 17 0.0026
382 HYPOKALAEMIA 118 0.0026
383 ESCHERICHIA INFECTION 21 0.0026
384 VENOUS THROMBOSIS 10 0.0025
385 CANDIDA INFECTION 43 0.0025
386 INTESTINAL ISCHAEMIA 14 0.0025
387 THERMAL BURN 18 0.0025
388 CARDIO-RESPIRATORY ARREST 106 0.0025
389 PLEURISY 15 0.0025
390 DIVERTICULUM INTESTINAL 11 0.0025
391 HAEMATOMA 65 0.0025
392 BONE LESION 9 0.0025
393 ILEUS 31 0.0025
394 ALTERED STATE OF CONSCIOUSNESS 54 0.0025
395 CHOLECYSTITIS ACUTE 14 0.0025
396 FOETAL GROWTH RESTRICTION 15 0.0025
397 DERMATITIS ALLERGIC 31 0.0025
398 BACTERIAL SEPSIS 8 0.0025
399 BLOOD ALKALINE PHOSPHATASE INCREASED 61 0.0025
400 PERIPHERAL ARTERIAL OCCLUSIVE DISEASE 10 0.0024
401 HYPOALBUMINAEMIA 19 0.0024
402 BLOOD ALBUMIN DECREASED 19 0.0024
403 NORMAL NEWBORN 13 0.0024
404 ATRIOVENTRICULAR BLOCK COMPLETE 16 0.0024
405 BLOOD UREA INCREASED 40 0.0024
406 CYTOMEGALOVIRUS INFECTION 39 0.0023
407 ALANINE AMINOTRANSFERASE INCREASED 144 0.0023
408 FEMORAL NECK FRACTURE 12 0.0023
409 BRONCHOPNEUMONIA 8 0.0023
410 CEREBRAL INFARCTION 57 0.0023
411 BLOOD CREATININE INCREASED 152 0.0023
412 UPPER GASTROINTESTINAL HAEMORRHAGE 39 0.0023
413 ACUTE RESPIRATORY FAILURE 44 0.0023
414 ASPARTATE AMINOTRANSFERASE INCREASED 121 0.0023
415 UROSEPSIS 21 0.0023
416 RASH VESICULAR 11 0.0023
417 PAPULE 16 0.0023
418 NYSTAGMUS 12 0.0023
419 CEREBRAL ATROPHY 9 0.0023
420 PULMONARY HYPERTENSION 47 0.0023
421 MENINGITIS 15 0.0022
422 CAESAREAN SECTION 26 0.0022
423 VASCULITIS 26 0.0022
424 HYPERKALAEMIA 78 0.0022
425 UNRESPONSIVE TO STIMULI 57 0.0022
426 PETECHIAE 23 0.0022
427 POLYURIA 18 0.0022
428 MYDRIASIS 28 0.0022
429 SPINAL COMPRESSION FRACTURE 18 0.0022
430 SINUS BRADYCARDIA 21 0.0022
431 HYPOPHOSPHATAEMIA 16 0.0022
432 RHABDOMYOLYSIS 90 0.0022
433 JAUNDICE 58 0.0022
434 URTICARIA 361 0.0022
435 PERIPHERAL VASCULAR DISORDER 11 0.0021
436 PREMATURE LABOUR 12 0.0021
437 NEUTROPHILIA 12 0.0021
438 CONCOMITANT DISEASE AGGRAVATED 13 0.0021
439 TROPONIN INCREASED 16 0.0021
440 LEFT VENTRICULAR HYPERTROPHY 9 0.0021
441 COMMUNICATION DISORDER 8 0.0021
442 FAECAL INCONTINENCE 10 0.0021
443 PERITONITIS 43 0.0021
444 DEPRESSED LEVEL OF CONSCIOUSNESS 82 0.0021
445 HAEMATOCRIT DECREASED 41 0.0021
446 HYPERTENSIVE CRISIS 23 0.0021
447 BRONCHOPULMONARY ASPERGILLOSIS 16 0.0021
448 FOETAL EXPOSURE DURING PREGNANCY 167 0.0021
449 SEPSIS 229 0.0021
450 PHYSICAL DISABILITY 9 0.0020
451 RHINITIS ALLERGIC 9 0.0020
452 RENAL CYST 16 0.0020
453 SMALL FOR DATES BABY 10 0.0020
454 EXPOSURE DURING PREGNANCY 125 0.0020
455 POOR QUALITY DRUG ADMINISTERED 13 0.0020
456 ATRIAL FLUTTER 16 0.0020
457 HYDRONEPHROSIS 15 0.0020
458 FLUID OVERLOAD 29 0.0020
459 ELECTROLYTE IMBALANCE 23 0.0020
460 IMMUNE THROMBOCYTOPENIA 9 0.0020
461 ISCHAEMIA 9 0.0020
462 PERIORBITAL SWELLING 11 0.0019
463 INTERVERTEBRAL DISC DEGENERATION 18 0.0019
464 CEREBRAL ISCHAEMIA 10 0.0019
465 HAEMOLYSIS 15 0.0019
466 DERMATITIS CONTACT 22 0.0019
467 LYMPHOCYTE COUNT DECREASED 34 0.0019
468 ORAL DISORDER 14 0.0019
469 MENTAL STATUS CHANGES 53 0.0019
470 CHOLELITHIASIS 62 0.0019
471 RESPIRATION ABNORMAL 13 0.0019
472 HYPOVOLAEMIC SHOCK 9 0.0019
473 MALNUTRITION 21 0.0019
474 COMPRESSION FRACTURE 10 0.0019
475 PERICARDIAL EFFUSION 42 0.0018
476 ATRIOVENTRICULAR BLOCK 14 0.0018
477 HYPOTONIA 18 0.0018
478 CYANOSIS 28 0.0018
479 ASCITES 52 0.0018
480 PULMONARY OEDEMA 79 0.0018
481 HEPATOCELLULAR INJURY 25 0.0018
482 TRICUSPID VALVE INCOMPETENCE 14 0.0018
483 PNEUMONIA ASPIRATION 44 0.0018
484 PERONEAL NERVE PALSY 10 0.0018
485 HEPATITIS 45 0.0018
486 ABSCESS 28 0.0018
487 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 18 0.0018
488 DRUG INTERACTION 278 0.0018
489 DRUG RESISTANCE 45 0.0018
490 ASPIRATION 19 0.0017
491 HYPOMAGNESAEMIA 24 0.0017
492 DEEP VEIN THROMBOSIS 112 0.0017
493 BONE MARROW FAILURE 35 0.0017
494 THROMBOCYTOPENIA 191 0.0017
495 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 15 0.0017
496 DECREASED INTEREST 10 0.0017
497 WHITE BLOOD CELL COUNT INCREASED 65 0.0017
498 DIALYSIS 24 0.0017
499 RESPIRATORY RATE INCREASED 15 0.0017
500 CHOLECYSTITIS 20 0.0017
501 CEREBRAL HAEMORRHAGE 60 0.0017
502 EMOTIONAL DISTRESS 202 0.0017
503 BLOOD BILIRUBIN INCREASED 45 0.0017
504 DIZZINESS POSTURAL 16 0.0016
505 DERMATITIS ACNEIFORM 10 0.0016
506 LEFT VENTRICULAR DYSFUNCTION 11 0.0016
507 BLOOD CREATINE PHOSPHOKINASE INCREASED 47 0.0016
508 CARDIAC MURMUR 14 0.0016
509 NECROSIS 9 0.0016
510 PYELONEPHRITIS 14 0.0016
511 SCOLIOSIS 10 0.0016
512 DELIRIUM 56 0.0016
513 CHOLANGITIS 10 0.0016
514 RASH ERYTHEMATOUS 77 0.0016
515 HAEMORRHAGE INTRACRANIAL 24 0.0016
516 NEPHROPATHY TOXIC 18 0.0016
517 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 12 0.0016
518 GRANULOCYTOPENIA 9 0.0016
519 NEUROLOGICAL SYMPTOM 9 0.0016
520 MYOCARDITIS 18 0.0016
521 SUPRAVENTRICULAR TACHYCARDIA 15 0.0016
522 URINARY RETENTION 52 0.0016
523 ERYTHEMA 320 0.0016
524 HYPERCALCAEMIA 19 0.0015
525 BONE DISORDER 28 0.0015
526 HYPOGAMMAGLOBULINAEMIA 10 0.0015
527 GRAND MAL CONVULSION 14 0.0015
528 SKIN INFECTION 17 0.0015
529 C-REACTIVE PROTEIN INCREASED 55 0.0015
530 RASH PUSTULAR 11 0.0015
531 ANAEMIA 287 0.0015
532 MATERNAL EXPOSURE DURING PREGNANCY 134 0.0015
533 LIP SWELLING 50 0.0015
534 LEUKOPENIA 75 0.0015
535 PYREXIA 518 0.0015
536 SENSORY DISTURBANCE 24 0.0015
537 ACUTE MYOCARDIAL INFARCTION 44 0.0015
538 RESPIRATORY ARREST 41 0.0015
539 METASTASES TO LYMPH NODES 10 0.0015
540 POST PROCEDURAL INFECTION 12 0.0015
541 ELECTROCARDIOGRAM QT PROLONGED 53 0.0015
542 HIATUS HERNIA 19 0.0015
543 HEPATIC FAILURE 44 0.0015
544 SPLENOMEGALY 17 0.0014
545 PHARYNGEAL SWELLING 14 0.0014
546 HYPOCALCAEMIA 27 0.0014
547 EXOSTOSIS 13 0.0014
548 HYPERLIPIDAEMIA 17 0.0014
549 LACTIC ACIDOSIS 46 0.0014
550 CONTRAINDICATED PRODUCT ADMINISTERED 43 0.0014
551 MELAENA 31 0.0014
552 INTERSTITIAL LUNG DISEASE 68 0.0014
553 C-REACTIVE PROTEIN ABNORMAL 9 0.0014
554 ELECTROCARDIOGRAM ABNORMAL 11 0.0014
555 PANCREATITIS 74 0.0014
556 DRUG LEVEL INCREASED 23 0.0014
557 RASH PRURITIC 75 0.0014
558 ARTERIOSCLEROSIS 13 0.0014
559 RASH 600 0.0014
560 ASPERGILLUS INFECTION 9 0.0014
561 NEUROTOXICITY 24 0.0014
562 PSYCHIATRIC SYMPTOM 10 0.0014
563 DECUBITUS ULCER 11 0.0013
564 NEUTROPHIL COUNT DECREASED 55 0.0013
565 MITRAL VALVE INCOMPETENCE 15 0.0013
566 EMBOLISM 11 0.0013
567 HEMIPLEGIA 11 0.0013
568 OSTEOPENIA 20 0.0013
569 GASTRIC ULCER 25 0.0013
570 SALIVARY HYPERSECRETION 13 0.0013
571 GLAUCOMA 25 0.0013
572 LARGE INTESTINE PERFORATION 9 0.0013
573 HYPERTRANSAMINASAEMIA 9 0.0013
574 FACIAL PARALYSIS 11 0.0013
575 FEBRILE NEUTROPENIA 85 0.0013
576 LACERATION 12 0.0013
577 OSTEOARTHRITIS 54 0.0013
578 PLATELET COUNT DECREASED 135 0.0013
579 LIVER INJURY 31 0.0013
580 HYPERBILIRUBINAEMIA 13 0.0013
581 OEDEMA 68 0.0013
582 ECONOMIC PROBLEM 19 0.0013
583 GROIN PAIN 11 0.0013
584 VENTRICULAR EXTRASYSTOLES 13 0.0013
585 MIOSIS 10 0.0012
586 ATRIAL FIBRILLATION 121 0.0012
587 DYSTONIA 24 0.0012
588 HAEMOGLOBIN DECREASED 127 0.0012
589 RESPIRATORY DISORDER 37 0.0012
590 BURSITIS 15 0.0012
591 INFECTION 178 0.0012
592 ANAL INCONTINENCE 11 0.0012
593 BLOOD PRESSURE DIASTOLIC DECREASED 9 0.0012
594 SWOLLEN TONGUE 38 0.0012
595 URINARY INCONTINENCE 36 0.0012
596 LIGAMENT SPRAIN 12 0.0012
597 SKIN LACERATION 13 0.0012
598 CHOLECYSTITIS CHRONIC 8 0.0012
599 RED BLOOD CELL COUNT DECREASED 34 0.0012
600 HAEMATEMESIS 30 0.0012
601 HEMIPARESIS 20 0.0012
602 HYPERGLYCAEMIA 43 0.0012
603 DEFORMITY 11 0.0012
604 PULMONARY ARTERIAL HYPERTENSION 17 0.0012
605 OSTEONECROSIS OF JAW 29 0.0012
606 PSYCHOLOGICAL TRAUMA 10 0.0012
607 RASH GENERALISED 30 0.0012
608 LYMPHADENOPATHY 41 0.0012
609 BLISTER 65 0.0012
610 LIVER DISORDER 51 0.0011
611 NO THERAPEUTIC RESPONSE 14 0.0011
612 TRANSFUSION 12 0.0011
613 HAEMATURIA 39 0.0011
614 PULMONARY CONGESTION 15 0.0011
615 TUMOUR LYSIS SYNDROME 10 0.0011
616 HYPONATRAEMIA 64 0.0011
617 BODY TEMPERATURE INCREASED 23 0.0011
618 EYE HAEMORRHAGE 15 0.0011
619 HEPATOMEGALY 11 0.0011
620 HAEMORRHAGE 117 0.0011
621 JOINT RANGE OF MOTION DECREASED 15 0.0011
622 RIB FRACTURE 23 0.0011
623 PRURITUS GENERALISED 24 0.0011
624 PALLOR 30 0.0011
625 CHILLS 129 0.0011
626 PNEUMOCYSTIS JIROVECII PNEUMONIA 11 0.0011
627 PULMONARY EMBOLISM 104 0.0011
628 ANXIETY 310 0.0011
629 DENTAL CARIES 12 0.0011
630 SKIN ULCER 28 0.0011
631 HAEMOPTYSIS 30 0.0011
632 NEUTROPHIL COUNT INCREASED 11 0.0011
633 HEPATIC STEATOSIS 20 0.0011
634 MUCOSAL INFLAMMATION 28 0.0011
635 BLOOD CALCIUM DECREASED 12 0.0011
636 FLANK PAIN 10 0.0011
637 ISCHAEMIC STROKE 19 0.0011
638 MEDICATION ERROR 59 0.0011
639 BLOOD SODIUM DECREASED 20 0.0011
640 SMALL INTESTINAL OBSTRUCTION 13 0.0011
641 AORTIC ANEURYSM 8 0.0011
642 SUBDURAL HAEMATOMA 15 0.0010
643 BLOOD POTASSIUM INCREASED 17 0.0010
644 MYOPATHY 9 0.0010
645 EPISTAXIS 77 0.0010
646 DRUG EXPOSURE DURING PREGNANCY 35 0.0010
647 VITAMIN D DEFICIENCY 10 0.0010
648 PANCREATITIS ACUTE 23 0.0010
649 IMMUNOSUPPRESSION 9 0.0010
650 EPILEPSY 31 0.0010
651 TOOTH LOSS 21 0.0010
652 PROCEDURAL PAIN 28 0.0010
653 OEDEMA PERIPHERAL 123 0.0010
654 BLADDER DISORDER 10 0.0010
655 MUSCLE RIGIDITY 12 0.0010
656 MYOSITIS 9 0.0010
657 FEMUR FRACTURE 31 0.0010
658 PLATELET COUNT INCREASED 13 0.0010
659 OBSTRUCTIVE AIRWAYS DISORDER 11 0.0010
660 HEPATOTOXICITY 22 0.0010
661 TOOTH ABSCESS 10 0.0010
662 MOTOR DYSFUNCTION 10 0.0010
663 THERAPY NON-RESPONDER 44 0.0010
664 HYPOPHAGIA 25 0.0010
665 METASTASES TO BONE 16 0.0010
666 MYOCARDIAL ISCHAEMIA 11 0.0010
667 ACUTE CORONARY SYNDROME 8 0.0010
668 NEPHROPATHY 9 0.0010
669 DISABILITY 19 0.0010
670 DIABETES MELLITUS INADEQUATE CONTROL 17 0.0010
671 PAIN IN JAW 27 0.0010
672 SUDDEN DEATH 10 0.0009
673 CONVULSION 54 0.0009
674 SCAR 16 0.0009
675 RESTLESSNESS 34 0.0009
676 NEUTROPENIA 126 0.0009
677 HYPERSENSITIVITY 172 0.0009
678 RHEUMATOID ARTHRITIS 105 0.0009
679 OESOPHAGITIS 10 0.0009
680 GASTRITIS 24 0.0009
681 ORAL CANDIDIASIS 12 0.0009
682 MUSCLE TWITCHING 21 0.0009
683 TOOTH FRACTURE 10 0.0009
684 ADRENAL INSUFFICIENCY 11 0.0009
685 TRANSAMINASES INCREASED 20 0.0009
686 HYPERTHYROIDISM 13 0.0009
687 BRAIN INJURY 9 0.0009
688 CARDIAC FAILURE 72 0.0009
689 PROTEINURIA 17 0.0009
690 ORAL PAIN 20 0.0009
691 INTESTINAL PERFORATION 10 0.0009
692 HEART RATE INCREASED 88 0.0009
693 EYELID PTOSIS 9 0.0009
694 HEART RATE DECREASED 31 0.0009
695 ARTHROPATHY 49 0.0009
696 DRUG TOXICITY 12 0.0009
697 BLOOD PRESSURE SYSTOLIC INCREASED 17 0.0009
698 HAEMORRHOIDS 17 0.0009
699 INTERVERTEBRAL DISC PROTRUSION 19 0.0009
700 APHASIA 26 0.0009
701 JOINT DISLOCATION 9 0.0009
702 OSTEOPOROSIS 35 0.0009
703 DYSARTHRIA 32 0.0008
704 WHEEZING 50 0.0008
705 ATAXIA 10 0.0008
706 CHROMATURIA 19 0.0008
707 THIRST 15 0.0008
708 SLEEP APNOEA SYNDROME 16 0.0008
709 NERVOUS SYSTEM DISORDER 26 0.0008
710 PRODUCT USE IN UNAPPROVED INDICATION 206 0.0008
711 MYELODYSPLASTIC SYNDROME 12 0.0008
712 OSTEONECROSIS 27 0.0008
713 GLOMERULAR FILTRATION RATE DECREASED 10 0.0008
714 DERMATITIS 17 0.0008
715 INJECTION SITE EXTRAVASATION 10 0.0008
716 PHARYNGITIS 10 0.0008
717 HALLUCINATION, VISUAL 17 0.0008
718 HYPOGLYCAEMIA 39 0.0008
719 RASH MACULAR 28 0.0008
720 HYPERTENSION 169 0.0008
721 GASTROOESOPHAGEAL REFLUX DISEASE 64 0.0008
722 GASTROINTESTINAL HAEMORRHAGE 66 0.0008
723 DYSKINESIA 32 0.0008
724 SWELLING FACE 51 0.0008
725 INTRAOCULAR PRESSURE INCREASED 10 0.0008
726 LETHARGY 45 0.0008
727 METASTASES TO LUNG 9 0.0008
728 ACUTE MYELOID LEUKAEMIA 12 0.0008
729 SKIN LESION 21 0.0008
730 PNEUMONIA 247 0.0008
731 HEPATIC ENZYME INCREASED 52 0.0008
732 ARRHYTHMIA 36 0.0008
733 BLOOD PRESSURE ABNORMAL 15 0.0008
734 LIVER FUNCTION TEST INCREASED 16 0.0007
735 ABDOMINAL DISCOMFORT 124 0.0007
736 COLITIS 28 0.0007
737 CONDITION AGGRAVATED 224 0.0007
738 AGITATION 54 0.0007
739 MUSCLE SPASTICITY 9 0.0007
740 DISORIENTATION 29 0.0007
741 BONE LOSS 11 0.0007
742 BLOOD POTASSIUM DECREASED 22 0.0007
743 IMPAIRED HEALING 24 0.0007
744 ABDOMINAL PAIN 170 0.0007
745 PHOTOSENSITIVITY REACTION 12 0.0007
746 MASS 10 0.0007
747 THYROID DISORDER 11 0.0007
748 ANKLE FRACTURE 11 0.0007
749 NEUROPATHY PERIPHERAL 67 0.0007
750 LOSS OF CONSCIOUSNESS 90 0.0007
751 CONFUSIONAL STATE 113 0.0007
752 INFUSION SITE PAIN 9 0.0007
753 ANOREXIA 9 0.0007
754 ANGINA PECTORIS 20 0.0007
755 CYTOKINE RELEASE SYNDROME 14 0.0007
756 PARAESTHESIA ORAL 10 0.0007
757 UPPER RESPIRATORY TRACT INFECTION 32 0.0007
758 BRONCHITIS 51 0.0007
759 URINARY TRACT INFECTION 117 0.0007
760 PRURITUS 261 0.0007
761 PAIN 417 0.0007
762 LIMB INJURY 18 0.0007
763 BACK PAIN 153 0.0007
764 PHARYNGEAL OEDEMA 10 0.0006
765 LIMB DISCOMFORT 20 0.0006
766 WHITE BLOOD CELL COUNT DECREASED 70 0.0006
767 HEAD INJURY 20 0.0006
768 GENERAL PHYSICAL HEALTH DETERIORATION 73 0.0006
769 FLUSHING 64 0.0006
770 PARALYSIS 9 0.0006
771 CYSTITIS 20 0.0006
772 HYPOTHYROIDISM 20 0.0006
773 METASTASES TO LIVER 11 0.0006
774 PULMONARY FIBROSIS 12 0.0006
775 RASH PAPULAR 14 0.0006
776 DYSPHAGIA 59 0.0006
777 LOCALISED INFECTION 15 0.0006
778 HYPOKINESIA 9 0.0006
779 COMPLICATION ASSOCIATED WITH DEVICE 9 0.0006
780 LIVER FUNCTION TEST ABNORMAL 18 0.0006
781 GASTROENTERITIS 9 0.0006
782 GALLBLADDER DISORDER 11 0.0006
783 PHARMACEUTICAL PRODUCT COMPLAINT 16 0.0006
784 VOMITING 288 0.0006
785 DYSPNOEA EXERTIONAL 23 0.0006
786 CARDIOMYOPATHY 9 0.0006
787 DEPRESSION 138 0.0006
788 HYPERHIDROSIS 78 0.0006
789 FLATULENCE 34 0.0006
790 DYSURIA 22 0.0006
791 HYPOAESTHESIA ORAL 9 0.0006
792 DYSPNOEA 337 0.0006
793 HIP FRACTURE 19 0.0006
794 FOOT FRACTURE 11 0.0006
795 EJECTION FRACTION DECREASED 9 0.0006
796 CONSTIPATION 126 0.0006
797 ORTHOSTATIC HYPOTENSION 10 0.0006
798 CARDIAC FAILURE CONGESTIVE 46 0.0006
799 VIRAL INFECTION 19 0.0006
800 FEELING HOT 35 0.0006
801 OBESITY 9 0.0006
802 LUNG DISORDER 27 0.0006
803 CHEST PAIN 102 0.0006
804 EYE PAIN 31 0.0005
805 ABDOMINAL DISTENSION 57 0.0005
806 DEHYDRATION 72 0.0005
807 SYNCOPE 54 0.0005
808 RENAL DISORDER 25 0.0005
809 PRODUCT PREPARATION ERROR 11 0.0005
810 RECTAL HAEMORRHAGE 23 0.0005
811 NEURALGIA 13 0.0005
812 SWELLING 50 0.0005
813 SEIZURE 61 0.0005
814 INFUSION RELATED REACTION 35 0.0005
815 POLLAKIURIA 22 0.0005
816 BLOOD PRESSURE INCREASED 80 0.0005
817 SKIN EXFOLIATION 44 0.0005
818 MUSCULAR WEAKNESS 59 0.0005
819 CHEST DISCOMFORT 53 0.0005
820 LOCAL SWELLING 9 0.0005
821 DRUG INEFFECTIVE 679 0.0005
822 PNEUMONITIS 14 0.0005
823 ORAL HERPES 10 0.0005
824 BONE PAIN 30 0.0005
825 CARDIOVASCULAR DISORDER 13 0.0005
826 STOMATITIS 31 0.0005
827 TREATMENT FAILURE 42 0.0005
828 INTESTINAL OBSTRUCTION 19 0.0005
829 INFLAMMATION 26 0.0005
830 PARAESTHESIA 79 0.0005
831 NEPHROLITHIASIS 23 0.0005
832 WOUND 14 0.0005
833 SEDATION 13 0.0005
834 CORONARY ARTERY DISEASE 15 0.0005
835 PRESYNCOPE 12 0.0005
836 DIABETES MELLITUS 37 0.0005
837 CONJUNCTIVITIS 9 0.0005
838 BURNING SENSATION 34 0.0005
839 OFF LABEL USE 424 0.0005
840 NECK PAIN 27 0.0005
841 THROAT TIGHTNESS 13 0.0005
842 NAUSEA 379 0.0005
843 TINNITUS 22 0.0005
844 BONE DENSITY DECREASED 15 0.0005
845 ADVERSE EVENT 44 0.0005
846 MOUTH ULCERATION 10 0.0005
847 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 26 0.0005
848 DECREASED APPETITE 110 0.0005
849 DISEASE RECURRENCE 22 0.0005
850 FALL 152 0.0005
851 COLD SWEAT 8 0.0005
852 SPINAL FRACTURE 9 0.0004
853 THERAPEUTIC PRODUCT EFFECT DECREASED 20 0.0004
854 SNEEZING 10 0.0004
855 COMA 21 0.0004
856 MUSCULOSKELETAL PAIN 23 0.0004
857 FEELING COLD 12 0.0004
858 VISUAL ACUITY REDUCED 14 0.0004
859 NERVOUSNESS 22 0.0004
860 SPEECH DISORDER 22 0.0004
861 BLOOD PRESSURE FLUCTUATION 10 0.0004
862 TOXICITY TO VARIOUS AGENTS 70 0.0004
863 HYPOAESTHESIA 62 0.0004
864 MENTAL DISORDER 18 0.0004
865 PRODUCT PRESCRIBING ISSUE 9 0.0004
866 DIARRHOEA 266 0.0004
867 CEREBROVASCULAR ACCIDENT 69 0.0004
868 HOSPITALISATION 62 0.0004
869 HERPES ZOSTER 23 0.0004
870 PRODUCTIVE COUGH 19 0.0004
871 GAIT DISTURBANCE 76 0.0004
872 PRODUCT AVAILABILITY ISSUE 9 0.0004
873 DISCOMFORT 24 0.0004
874 COUGH 110 0.0004
875 ERECTILE DYSFUNCTION 10 0.0004
876 CATARACT 23 0.0004
877 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 9 0.0004
878 THROMBOSIS 31 0.0004
879 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 20 0.0004
880 DEAFNESS 10 0.0004
881 SOMNOLENCE 76 0.0004
882 DIABETIC KETOACIDOSIS 9 0.0004
883 TREMOR 62 0.0004
884 LABORATORY TEST ABNORMAL 11 0.0004
885 DISEASE PROGRESSION 44 0.0004
886 DISTURBANCE IN ATTENTION 20 0.0004
887 ARTHRITIS 29 0.0004
888 BLINDNESS 15 0.0004
889 LACRIMATION INCREASED 11 0.0004
890 COGNITIVE DISORDER 17 0.0004
891 MYELOSUPPRESSION 13 0.0004
892 ARTHRALGIA 150 0.0004
893 HALLUCINATION 27 0.0004
894 TYPE 2 DIABETES MELLITUS 12 0.0004
895 ACCIDENTAL OVERDOSE 13 0.0004
896 PAIN IN EXTREMITY 104 0.0004
897 SKIN DISCOLOURATION 16 0.0003
898 DIPLOPIA 9 0.0003
899 DEVICE DISLOCATION 15 0.0003
900 ASTHENIA 128 0.0003
901 RHINORRHOEA 22 0.0003
902 MALIGNANT NEOPLASM PROGRESSION 34 0.0003
903 JOINT SWELLING 40 0.0003
904 MYALGIA 56 0.0003
905 HAEMATOCHEZIA 18 0.0003
906 ECZEMA 17 0.0003
907 INFLUENZA 36 0.0003
908 OCULAR HYPERAEMIA 15 0.0003
909 MYOCARDIAL INFARCTION 55 0.0003
910 VISION BLURRED 43 0.0003
911 MOVEMENT DISORDER 10 0.0003
912 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 22 0.0003
913 OVERDOSE 66 0.0003
914 PSYCHOTIC DISORDER 9 0.0003
915 PRODUCT USE ISSUE 57 0.0003
916 WRONG TECHNIQUE IN DRUG USAGE PROCESS 11 0.0003
917 ASTHMA 34 0.0003
918 BLOOD CHOLESTEROL INCREASED 14 0.0003
919 SKIN DISORDER 10 0.0003
920 EYE SWELLING 11 0.0003
921 DRUG ADMINISTRATION ERROR 9 0.0003
922 SKIN BURNING SENSATION 21 0.0003
923 TREATMENT NONCOMPLIANCE 16 0.0003
924 EMOTIONAL DISORDER 9 0.0003
925 COVID-19 51 0.0003
926 THROAT IRRITATION 13 0.0003
927 ROAD TRAFFIC ACCIDENT 12 0.0003
928 CONTUSION 27 0.0003
929 INCORRECT ROUTE OF DRUG ADMINISTRATION 10 0.0003
930 MOBILITY DECREASED 20 0.0003
931 AMNESIA 18 0.0003
932 DYSPEPSIA 27 0.0003
933 MUSCULOSKELETAL STIFFNESS 24 0.0003
934 PALPITATIONS 32 0.0003
935 NASAL CONGESTION 16 0.0003
936 BLOOD GLUCOSE DECREASED 13 0.0003
937 COLITIS ULCERATIVE 12 0.0003
938 MUSCLE SPASMS 49 0.0003
939 TRANSIENT ISCHAEMIC ATTACK 9 0.0003
940 DIZZINESS 132 0.0003
941 WITHDRAWAL SYNDROME 11 0.0003
942 MALAISE 114 0.0003
943 DRUG EFFECT DECREASED 14 0.0003
944 CARDIAC DISORDER 24 0.0003
945 FLUID RETENTION 13 0.0003
946 WEIGHT DECREASED 71 0.0003
947 ABNORMAL BEHAVIOUR 10 0.0003
948 HOT FLUSH 19 0.0003
949 IRRITABILITY 15 0.0002
950 DRY EYE 12 0.0002
951 AGGRESSION 12 0.0002
952 DYSPHONIA 14 0.0002
953 DEATH 206 0.0002
954 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 8 0.0002
955 INSOMNIA 63 0.0002
956 PERIPHERAL SWELLING 36 0.0002
957 THERAPEUTIC RESPONSE DECREASED 14 0.0002
958 HEADACHE 143 0.0002
959 OROPHARYNGEAL PAIN 21 0.0002
960 SINUSITIS 23 0.0002
961 GASTROINTESTINAL DISORDER 20 0.0002
962 SURGERY 13 0.0002
963 BALANCE DISORDER 19 0.0002
964 UNDERDOSE 16 0.0002
965 ABDOMINAL PAIN UPPER 45 0.0002
966 DRUG INTOLERANCE 21 0.0002
967 PRODUCT DOSE OMISSION 14 0.0002
968 VERTIGO 13 0.0002
969 MEMORY IMPAIRMENT 27 0.0002
970 FATIGUE 149 0.0002
971 DRY MOUTH 15 0.0002
972 NASOPHARYNGITIS 34 0.0002
973 SLEEP DISORDER 13 0.0002
974 WEIGHT INCREASED 40 0.0002
975 THERAPY CESSATION 9 0.0002
976 DEVICE MALFUNCTION 12 0.0002
977 ALOPECIA 33 0.0002
978 MIGRAINE 16 0.0002
979 BLOOD GLUCOSE INCREASED 31 0.0002
980 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 29 0.0002
981 DRUG WITHDRAWAL SYNDROME 14 0.0002
982 NO ADVERSE EVENT 28 0.0002
983 PSORIASIS 20 0.0002
984 INTENTIONAL PRODUCT USE ISSUE 13 0.0001
985 PRODUCT QUALITY ISSUE 19 0.0001
986 INFLUENZA LIKE ILLNESS 11 0.0001
987 FEELING ABNORMAL 31 0.0001
988 VISUAL IMPAIRMENT 16 0.0001
989 ADVERSE DRUG REACTION 10 0.0001
990 SUICIDAL IDEATION 10 0.0001
991 BREAST CANCER 9 0.0001
992 INCORRECT DOSE ADMINISTERED 17 0.0001
993 DRUG DEPENDENCE 11 0.0001
994 PRODUCT DOSE OMISSION ISSUE 17 0.0001
995 INJECTION SITE PAIN 11 0.0000